CoChat

Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling

Centenera, Margaret M., Harris, Jonathan M., Tilley, Wayne D., Butler, Lisa M. · 2008 · Molecular Endocrinology
Cited by 145

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The androgen receptor (AR) is a ligand-activated transcription factor of the nuclear receptor superfamily that plays a critical role in male physiology and pathology. Activated by binding of the native androgens testosterone and 5alpha-dihydrotestosterone, the AR regulates transcription of genes involved in the development and maintenance of male phenotype and male reproductive function as well as other tissues such as bone and muscle. Deregulation of AR signaling can cause a diverse range of clinical conditions, including the X-linked androgen insensitivity syndrome, a form of motor neuron disease known as Kennedy's disease, and male infertility. In addition, there is now compelling evidence that the AR is involved in all stages of prostate tumorigenesis including initiation, progression, and treatment resistance. To better understand the role of AR signaling in the pathogenesis of these conditions, it is important to have a comprehensive understanding of the key determinants of AR structure and function. Binding of androgens to the AR induces receptor dimerization, facilitating DNA binding and the recruitment of cofactors and transcriptional machinery to regulate expression of target genes. Various models of dimerization have been described for the AR, the most well characterized interaction being DNA-binding domain- mediated dimerization, which is essential for the AR to bind DNA and regulate transcription. Additional AR interactions with potential to contribute to receptor dimerization include the intermolecular interaction between the AR amino terminal domain and ligand-binding domain known as the N-terminal/C-terminal interaction, and ligand-binding domain dimerization. In this review, we discuss each form of dimerization utilized by the AR to achieve transcriptional competence and highlight that dimerization through multiple domains is necessary for optimal AR signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2008-0017

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 83

  1. Jones, 1995, Protein-protein interactions: a review of protein dimer structures., Prog Biophys Mol Biol, 63, 31, 10.1016/0079-6107(94)00008-W · DOI · Paper page
  2. Glass, 1994, Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers., Endocr Rev, 15, 391
  3. Forman, 1990, Dimerization among nuclear hormone receptors., New Biol, 2, 587
  4. Brinkmann, 1989, The human androgen receptor: domain structure, genomic organization and regulation of expression., J Steroid Biochem, 34, 307, 10.1016/0022-4731(89)90098-8 · DOI · Paper page
  5. Gioeli, 2002, Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites., J Biol Chem, 277, 29304, 10.1074/jbc.M204131200 · DOI · Paper page
  6. Marcelli, 2006, Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility., J Cell Biochem, 98, 770, 10.1002/jcb.20593 · DOI
  7. Claessens, 2001, Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation., J Steroid Biochem Mol Biol, 76, 23, 10.1016/S0960-0760(00)00154-0 · DOI · Paper page
  8. Ham, 1988, Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus., Nucleic Acids Res, 16, 5263, 10.1093/nar/16.12.5263 · DOI · Paper page
  9. Cleutjens, 1997, Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells., Endocrinology, 138, 5293, 10.1210/endo.138.12.5564 · DOI
  10. Funder, 1993, Mineralocorticoids, glucocorticoids, receptors and response elements., Science, 259, 1132, 10.1126/science.8382375 · DOI · Paper page
  11. Lambert, 1998, Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration., J Biol Chem, 273, 32708, 10.1074/jbc.273.49.32708 · DOI
  12. Beato, 1995, Steroid hormone receptors: many actors in search of a plot., Cell, 83, 851, 10.1016/0092-8674(95)90201-5 · DOI · Paper page
  13. Adler, 1993, The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences., Mol Cell Biol, 13, 6326, 10.1128/MCB.13.10.6326 · DOI · Paper page
  14. Truss, 1993, Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors., Endocr Rev, 14, 459
  15. Tsai, 1988, Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation., Cell, 55, 361, 10.1016/0092-8674(88)90059-1 · DOI · Paper page
  16. Dahlman-Wright, 1991, Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids., J Biol Chem, 266, 3107, 10.1016/S0021-9258(18)49960-7 · DOI · Paper page
  17. Freedman, 1988, The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain., Nature, 334, 543, 10.1038/334543a0 · DOI · Paper page
  18. Umesono, 1989, Determinants of target gene specificity for steroid/thyroid hormone receptors., Cell, 57, 1139, 10.1016/0092-8674(89)90051-2 · DOI · Paper page
  19. Remerowski, 1991, 1H NMR studies of DNA recognition by the glucocorticoid receptor: complex of the DNA binding domain with a half-site response element., Biochemistry, 30, 11620, 10.1021/bi00114a003 · DOI
  20. Nazareth, 1999, A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)., Mol Endocrinol, 13, 2065, 10.1210/mend.13.12.0382 · doi:10.1210/mend.13.12.0382 · Paper page
  21. Schoenmakers, 2000, Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses., J Biol Chem, 275, 12290, 10.1074/jbc.275.16.12290 · DOI · Paper page
  22. Schoenmakers, 1999, Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains., Biochem J, 341, 515, 10.1042/bj3410515 · DOI · Paper page
  23. Haelens, 2001, Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene., Biochem J, 353, 611, 10.1042/bj3530611 · doi:10.1042/bj3530611 · Paper page
  24. Hard, 1990, Solution structure of the glucocorticoid receptor DNA-binding domain., Science, 249, 157, 10.1126/science.2115209 · DOI · Paper page
  25. Schwabe, 1993, The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements., Cell, 75, 567, 10.1016/0092-8674(93)90390-C · DOI · Paper page
  26. Aumais, 1996, Function of directly repeated half-sites as response elements for steroid hormone receptors., J Biol Chem, 271, 12568, 10.1074/jbc.271.21.12568 · DOI
  27. Wilson, 1992, Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors., Science, 256, 107, 10.1126/science.1314418 · DOI · Paper page
  28. Rastinejad, 1995, Structural determinants of nuclear receptor assembly on DNA direct repeats., Nature, 375, 203, 10.1038/375203a0 · DOI · Paper page
  29. Lee, 1993, Structure of the retinoid X receptor α DNA binding domain: a helix required for homodimeric DNA binding., Science, 260, 1117, 10.1126/science.8388124 · DOI · Paper page
  30. Wong, 1993, Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains., J Biol Chem, 268, 19004, 10.1016/S0021-9258(17)46727-5 · DOI · Paper page
  31. Wang, 2007, A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth., Mol Cell, 27, 380, 10.1016/j.molcel.2007.05.041 · DOI · Paper page
  32. Bolton, 2007, Cell- and gene-specific regulation of primary target genes by the androgen receptor., Genes Dev, 21, 2005, 10.1101/gad.1564207 · DOI · Paper page
  33. Claessens, 1996, The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors., J Biol Chem, 271, 19013, 10.1074/jbc.271.32.19013 · DOI · Paper page
  34. Rennie, 1993, Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene., Mol Endocrinol, 7, 23
  35. Verrijdt, 1999, Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element., Mol Endocrinol, 13, 1558, 10.1210/mend.13.9.0347 · DOI · Paper page
  36. Kasper, 1994, Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene., J Biol Chem, 269, 31763, 10.1016/S0021-9258(18)31761-7 · DOI · Paper page
  37. Haelens, 2003, DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation., Biochem J, 369, 141, 10.1042/bj20020912 · DOI · Paper page
  38. He, 2004, Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance., Mol Cell, 16, 425, 10.1016/j.molcel.2004.09.036 · DOI · Paper page
  39. He, 1999, Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain., J Biol Chem, 274, 37219, 10.1074/jbc.274.52.37219 · DOI · Paper page
  40. He, 2000, FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor., J Biol Chem, 275, 22986, 10.1074/jbc.M002807200 · DOI · Paper page
  41. He, 2002, The NH2-terminal and carboxyl-terminal interaction in the human androgen receptor., Mol Genet Metab, 75, 293, 10.1016/S1096-7192(02)00009-4 · DOI
  42. Kemppainen, 1999, Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone., Mol Endocrinol, 13, 440, 10.1210/mend.13.3.0255 · doi:10.1210/mend.13.3.0255 · Paper page
  43. Li, 2006, A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin., Mol Endocrinol, 20, 776, 10.1210/me.2005-0298 · DOI
  44. Matias, 2000, Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations., J Biol Chem, 275, 26164, 10.1074/jbc.M004571200 · DOI · Paper page
  45. Jenster, 1995, Identification of two transcription activation units in the N-terminal domain of the human androgen receptor., J Biol Chem, 270, 7341, 10.1074/jbc.270.13.7341 · DOI · Paper page
  46. He, 2001, Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2., J Biol Chem, 276, 42293, 10.1074/jbc.M107492200 · DOI · Paper page
  47. He, 2002, The FXXLF motif mediates androgen receptor-specific interactions with coregulators., J Biol Chem, 277, 10226, 10.1074/jbc.M111975200 · DOI · Paper page
  48. Burd, 2005, Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression., Mol Endocrinol, 19, 607, 10.1210/me.2004-0266 · DOI · Paper page
  49. Bai, 2005, Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction., Mol Cell Biol, 25, 1238, 10.1128/MCB.25.4.1238-1257.2005 · DOI · Paper page
  50. Bai, 2008, Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation., Mol Hum Reprod, 14, 107, 10.1093/molehr/gam080 · DOI
  51. Gregory, 2001, A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy., Cancer Res, 61, 4315
  52. He, 2006, Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity., J Biol Chem, 281, 6648, 10.1074/jbc.M511738200 · DOI
  53. Royen, 2007, Compartmentalization of androgen receptor protein-protein interactions in living cells., J Cell Biol, 177, 63, 10.1083/jcb.200609178 · DOI · Paper page
  54. Ikonen, 1997, Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators., J Biol Chem, 272, 29821, 10.1074/jbc.272.47.29821 · DOI · Paper page
  55. Shen, 2005, GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor., Biol Chem, 386, 69, 10.1515/BC.2005.009 · DOI · Paper page
  56. Irvine, 2000, Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length., Hum Mol Genet, 9, 267, 10.1093/hmg/9.2.267 · DOI · Paper page
  57. Zhou, 1995, Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability., Mol Endocrinol, 9, 208
  58. Buchanan, 2004, Structural and functional consequences of glutamine tract variation in the androgen receptor., Hum Mol Genet, 13, 1677, 10.1093/hmg/ddh181 · DOI · Paper page
  59. Callewaert, 2003, Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements., J Biol Chem, 278, 8212, 10.1074/jbc.M210744200 · DOI · Paper page
  60. Thompson, 2001, Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity., Mol Endocrinol, 15, 923, 10.1210/mend.15.6.0647 · doi:10.1210/mend.15.6.0647 · Paper page
  61. Ghali, 2003, The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity., J Clin Endocrinol Metab, 88, 2185, 10.1210/jc.2002-021324 · DOI
  62. Jaaskelainen, 2006, Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains., J Mol Endocrinol, 36, 361, 10.1677/jme.1.01885 · DOI
  63. Savory, 2001, Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces., Mol Cell Biol, 21, 781, 10.1128/MCB.21.3.781-793.2001 · DOI · Paper page
  64. Fawell, 1990, Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor., Cell, 60, 953, 10.1016/0092-8674(90)90343-D · DOI · Paper page
  65. Perlmann, 1996, Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors., Mol Endocrinol, 10, 958
  66. Mangelsdorf, 1995, The RXR heterodimers and orphan receptors., Cell, 83, 841, 10.1016/0092-8674(95)90200-7 · DOI · Paper page
  67. Williams, 1998, Atomic structure of progesterone complexed with its receptor., Nature, 393, 392, 10.1038/30775 · DOI · Paper page
  68. Nemoto, 1994, Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor., J Steroid Biochem Mol Biol, 50, 225, 10.1016/0960-0760(94)90126-0 · DOI
  69. Lees, 1990, A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor., Mol Cell Biol, 10, 5529, 10.1128/MCB.10.10.5529 · DOI
  70. DeMarzo, 1991, Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein., Proc Natl Acad Sci USA, 88, 72, 10.1073/pnas.88.1.72 · DOI · Paper page
  71. Doesburg, 1997, Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor., Biochemistry, 36, 1052, 10.1021/bi961775g · DOI · Paper page
  72. Berrevoets, 1998, Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)., Mol Endocrinol, 12, 1172, 10.1210/mend.12.8.0153 · doi:10.1210/mend.12.8.0153 · Paper page
  73. Gampe, 2000, Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors., Mol Cell, 5, 545, 10.1016/S1097-2765(00)80448-7 · DOI · Paper page
  74. Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α., Nature, 375, 377, 10.1038/375377a0 · DOI · Paper page
  75. Tanenbaum, 1998, Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains., Proc Natl Acad Sci USA, 95, 5998, 10.1073/pnas.95.11.5998 · DOI · Paper page
  76. Caamano, 1998, A conserved proline in the hsp90 binding region of the glucocorticoid receptor is required for hsp90 heterocomplex stabilization and receptor signaling., J Biol Chem, 273, 20473, 10.1074/jbc.273.32.20473 · DOI · Paper page
  77. Marcelli, 1994, Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex., J Clin Invest, 94, 1642, 10.1172/JCI117507 · DOI · Paper page
  78. Bouvattier, 2002, Postnatal changes of T, LH, and FSH in 46, XY infants with mutations in the AR gene., J Clin Endocrinol Metab, 87, 29, 10.1210/jcem.87.1.7923 · doi:10.1210/jcem.87.1.7923 · Paper page
  79. Ahmed, 2000, Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome., J Clin Endocrinol Metab, 85, 658
  80. Butler, 2006, Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant., Mol Endocrinol, 20, 1009, 10.1210/me.2004-0401 · DOI
  81. Ikonen, 1998, Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms., FEBS Lett, 430, 393, 10.1016/S0014-5793(98)00701-7 · DOI
  82. Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice., Nucleic Acids Res, 22, 4673, 10.1093/nar/22.22.4673 · DOI · Paper page
  83. Guex, 1997, SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling., Electrophoresis, 18, 2714, 10.1002/elps.1150181505 · DOI · Paper page

Cited by

See all 145

Metadata

Authors
Centenera, M. M., Harris, J. M., Tilley, W. D., & Butler, L. M.
Venue
Molecular Endocrinology
Published
2008-11-01
Volume
22
Issue
11
Pages
2373-2382
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2036994464
Cited by
145
References
19
FWCI
9.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling. https://app.cochat.ai/papers/10.1210/me.2008-0017
The paper
Centenera, M. M., Harris, J. M., Tilley, W. D., & Butler, L. M. (2008). Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling. Molecular Endocrinology. https://doi.org/10.1210/me.2008-0017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.